CLINICAL SUPPLY MANAGEMENT ARTICLES
Does Clinical Development Really Need An S&OP?
Clinical supply S&OP can align demand, CDMO capacity, inventory and program trade-offs, but central planning and a clinical-focused D&OP model may work better.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.
-
Sponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
Patient enrollment can vary widely due to a number of variables, introducing risk into the supply chain. Here's why its critical to be aware of these risks and how best to mitigate them within trials.
-
Interactive response technology (IRT) systems ensure clinical trial participants receive the correct treatment, facilitate enhanced logistics tracking, and empower users to obtain real-time data.
-
Rachel Curran, Head of Sourcing Services and Special Accounts, discusses the requirements, challenges, and solutions to comparator and co-therapy drug sourcing for clinical trials.
-
Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.